α-Pyrrolidinoheptaphenone

Edit links
Source: Wikipedia, the free encyclopedia.


α-Pyrrolidinoheptaphenone
Clinical data
Other namesα-PHPP; alpha-PHPP; alpha-Pyrrolidinoheptiophenone; alpha-Pyrrolidinoheptanophenone; PV-8; PV8; Aphpp; A-PHPP
Legal status
Legal status
Identifiers
  • 1-Phenyl-2-pyrrolidin-1-ylheptan-1-one
JSmol)
  • CCCCCC(C(=O)C1=CC=CC=C1)N2CCCC2
  • InChI=1S/C17H25NO/c1-2-3-5-12-16(18-13-8-9-14-18)17(19)15-10-6-4-7-11-15/h4,6-7,10-11,16H,2-3,5,8-9,12-14H2,1H3
  • Key:DLRWKNLMJAIFQB-UHFFFAOYSA-N

α-Pyrrolidinoheptaphenone (PV8, α-PEP, α-PHPP, Aphpp, A-PHPP) is a designer drug of the pyrrolidinophenone class of cathinones.[1][2] It is the higher homolog of α-pyrrolidinohexiophenone (α-PHP).

In the United States, α-pyrrolidinoheptaphenone is a

Schedule I Controlled Substance.[3]

See also

References

  1. S2CID 8271553
    .
  2. PMID 24769262
    .
  3. ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-30.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Α-Pyrrolidinoheptaphenone&oldid=1215335858"